Literature DB >> 10379358

Genetics and molecular pathogenesis of mitochondrial respiratory chain diseases.

M G Hanna1, I P Nelson.   

Abstract

Dysfunction of the mitochondrial respiratory chain has been recognised as a cause of human disease for over 30 years. Advances in the past 10 years have led to a better understanding of the genetics and molecular pathogenesis of many of these disorders. Over 100 primary defects in mitochondrial DNA (mtDNA) are now implicated in the pathogenesis of a group of disorders which are collectively known as the mitochondrial encephalomyopathies, and which most frequently involve skeletal muscle and/or the central nervous system. Although impaired oxidative phosphorylation is likely to be the final common pathway leading to the cellular dysfunction associated with such mtDNA mutations, the complex relationship between genotype and phenotype remains largely unexplained. Most of the genes which encode the respiratory chain reside in the nucleus, yet only five nuclear genes have been implicated in human respiratory chain diseases. There is evidence that respiratory chain dysfunction is present in common neurological diseases such as Parkinson's disease and Huntington's disease. The precise cause of this respiratory chain dysfunction and its relationship to the disease process are unclear. This review focuses upon respiratory chain disorders associated with primary defects in mtDNA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10379358     DOI: 10.1007/s000180050327

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  6 in total

1.  Microphotometric analysis of NADH-tetrazolium reductase deficiency in fibroblasts of patients with Leber hereditary optic neuropathy.

Authors:  S Malik; H Sudoyo; S Marzuki
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

2.  Frequency of mitochondrial transfer RNA mutations and deletions in 225 patients presenting with respiratory chain deficiencies.

Authors:  M Jaksch; S Kleinle; C Scharfe; T Klopstock; D Pongratz; J Müller-Höcker; K D Gerbitz; S Liechti-Gallati; H Lochmuller; R Horvath
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

3.  Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease.

Authors:  Doris D M Lin; Thomas O Crawford; Peter B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

4.  Characteristics of intestinal pseudo-obstruction in patients with mitochondrial diseases.

Authors:  Yusuke Sekino; Masahiko Inamori; Eiji Yamada; Hidenori Ohkubo; Eiji Sakai; Takuma Higurashi; Hiroshi Iida; Kunihiro Hosono; Hiroki Endo; Takashi Nonaka; Hirokazu Takahashi; Tomoko Koide; Yasunobu Abe; Eiji Gotoh; Shigeru Koyano; Yoshiyuki Kuroiwa; Shin Maeda; Atsushi Nakajima
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

5.  ALS/FTD-associated protein FUS induces mitochondrial dysfunction by preferentially sequestering respiratory chain complex mRNAs.

Authors:  Yueh-Lin Tsai; Tristan H Coady; Lei Lu; Dinghai Zheng; Isabel Alland; Bin Tian; Neil A Shneider; James L Manley
Journal:  Genes Dev       Date:  2020-05-07       Impact factor: 11.361

6.  Comparative transcriptome profiling of two Brassica napus cultivars under chromium toxicity and its alleviation by reduced glutathione.

Authors:  Rafaqat A Gill; Basharat Ali; Peng Cui; Enhui Shen; Muhammad A Farooq; Faisal Islam; Shafaqat Ali; Bizeng Mao; Weijun Zhou
Journal:  BMC Genomics       Date:  2016-11-07       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.